Natural Health Trends Reports Third Quarter 2025 Financial Results
Natural Health Trends (NASDAQ: NHTC) reported third quarter 2025 results with Q3 revenue of $9.5 million, down 11% year‑over‑year, and an operating loss of $495,000. Net loss was $431,000, or $0.04 per diluted share. Management announced a major restructuring expected to deliver $1.5 million in annualized savings by mid‑2026 and a one‑time fourth‑quarter charge of approximately $250,000. Total cash, cash equivalents and marketable securities were $32.0 million at September 30, 2025, down from $43.9 million at year‑end 2024. The board declared a $0.20 quarterly cash dividend payable November 28, 2025, and management disclosed an expected reduction to $0.10 per share beginning Q1 2026.
Natural Health Trends (NASDAQ: NHTC) ha riportato i risultati del terzo trimestre 2025 con ricavi del Q3 pari a 9,5 milioni di dollari, in calo dell'11% anno su anno, e una perdita operativa di 495.000 dollari. La perdita netta è stata di 431.000 dollari, o 0,04 dollari per azione diluita. La direzione ha annunciato una riorganizzazione importante che si prevede genererà risparmi annualizzati di 1,5 milioni di dollari entro la metà del 2026 e una spesa una tantum del quarto trimestre di circa 250.000 dollari. Il totale di cassa, equivalenti di cassa e titoli negoziabili era di 32,0 milioni di dollari al 30 settembre 2025, in calo rispetto ai 43,9 milioni al 31 dicembre 2024. Il consiglio ha dichiarato un dividendo in contanti trimestrale di 0,20 dollari pagabile il 28 novembre 2025, e la direzione ha indicato una prevista riduzione a 0,10 dollari per azione a partire dal primo trimestre 2026.
Natural Health Trends (NASDAQ: NHTC) informó resultados del tercer trimestre de 2025 con ingresos del Q3 de 9,5 millones de dólares, una caída del 11% interanual, y una pérdida operativa de 495.000 dólares. La pérdida neta fue de 431.000 dólares, o 0,04 dólares por acción diluida. La dirección anunció una restructuración importante que se espera genere ahorros anualizados de 1,5 millones de dólares para mediados de 2026 y una carga única del cuarto trimestre de aproximadamente 250.000 dólares. El efectivo y equivalentes y valores negociables totalizaron 32,0 millones de dólares al 30 de septiembre de 2025, frente a 43,9 millones al cierre de 2024. La junta declaró un dividendo en efectivo trimestral de 0,20 dólares pagadero el 28 de noviembre de 2025, y la dirección comunicó una reducción prevista a 0,10 dólares por acción a partir del primer trimestre de 2026.
Natural Health Trends (NASDAQ: NHTC) 는 2025년 3분기 실적을 발표했습니다. 3분기 매출은 950만 달러, 전년 동기 대비 11% 감소, 그리고 영업손실은 49만 5천 달러였습니다. 순손실은 43만 1천 달러, 희석 주당 0.04달러였습니다. 경영진은 대대적인 구조조정을 발표했고, 이를 통해 2026년 중반까지 연간 150만 달러의 절감 효과를 기대하며, 4분기에 약 25만 달러의 일회성 비용이 발생할 예정입니다. 2025년 9월 30일 기준 현금, 현금등가물 및 시장성 있는 유가증권의 합계는 3200만 달러였으며, 2024년 말의 4390만 달러에서 감소했습니다. 이사회는 2025년 11월 28일 지급 예정인 분기 현금 배당 0.20달러를 승인했고, 경영진은 2026년 1분기부터 주당 0.10달러로의 감액을 예고했습니다.
Natural Health Trends (NASDAQ: NHTC) a publié les résultats du troisième trimestre 2025 avec un chiffre d'affaires du T3 de 9,5 millions de dollars, en baisse de 11% d'une année sur l'autre, et une perte opérationnelle de 495 000 dollars. La perte nette était de 431 000 dollars, soit 0,04 dollar par action diluée. La direction a annoncé une réorganisation majeure qui devrait générer des économies annuelles de 1,5 million de dollars d'ici la mi-2026 et une charge unique pour le quatrième trimestre d'environ 250 000 dollars. Le total de liquidités, équivalents de liquidités et valeurs mobilières s'élevait à 32,0 millions de dollars au 30 septembre 2025, en baisse par rapport à 43,9 millions à la fin de l'exercice 2024. Le conseil d'administration a déclaré un dividende trimestriel en espèces de 0,20 dollar payable le 28 novembre 2025, et la direction a indiqué une réduction attendue à 0,10 dollar par action à partir du premier trimestre 2026.
Natural Health Trends (NASDAQ: NHTC) hat die Ergebnisse des dritten Quartals 2025 mit einem Umsatz im Q3 von 9,5 Mio. USD, einem Rückgang von 11% gegenüber dem Vorjahr, und einem Betriebsergebnis von -495.000 USD gemeldet. Der Nettogewinn betrug -431.000 USD, bzw. 0,04 USD je verwässerter Aktie. Das Management kündigte eine große Umstrukturierung an, die voraussichtlich jährliche Einsparungen von 1,5 Mio. USD bis Mitte 2026 bringen wird, sowie eine Einmalbelastung für das vierte Quartal von ca. 250.000 USD. Insgesamt an Bargeld, Bargeldäquivalenten und handelbaren Wertpapieren betrug am 30. September 2025 32,0 Mio. USD, gegenüber 43,9 Mio. USD zum Jahresende 2024. Der Vorstand genehmigte eine quartalsweise Barausschüttung von 0,20 USD, zahlbar am 28. November 2025, und das Management gab eine Reduktion auf 0,10 USD pro Aktie ab dem ersten Quartal 2026 bekannt.
Natural Health Trends (NASDAQ: NHTC) أبلغت عن نتائج الربع الثالث 2025 مع إيرادات الربع الثالث 9,5 مليون دولار، بانخفاض قدره 11% عن العام السابق، و< b>خسارة تشغيلية قدرها 495,000 دولار. كانت الخسارة الصافية 431,000 دولار، أو 0,04 دولار للسهم المخفف. أعلنت الإدارة عن إعادة هيكلة كبيرة من المتوقع أن تحقق وفرًا سنويًا قدره 1,5 مليون دولار بحلول منتصف 2026 وتكلفة لامرة واحدة في الربع الرابع تقارب 250,000 دولار. كان الإجمالي النقدي وما يعادله من النقد والأسهم القابلة للتداول 32,0 مليون دولار في 30 سبتمبر 2025، انخفاضًا من 43,9 مليون دولار بنهاية 2024. أعلن المجلس عن توزيع نقدي ربع سنوي قدره 0,20 دولار، ويدفع في 28 نوفمبر 2025، وأفادت الإدارة بتخفيض متوقع إلى 0,10 دولار للسهم اعتبارًا من الربع الأول 2026.
- $1.5 million expected annualized cost savings by mid‑2026
- Board declared $0.20 quarterly cash dividend payable Nov 28, 2025
- Maintained $32.0 million in cash, cash equivalents and marketable securities
- Q3 revenue declined 11% YoY to $9.5 million
- Reported Q3 net loss of $431,000 (vs. net income prior year)
- Net cash used in operating activities of $5.0 million in first nine months 2025
- Cash and equivalents declined 27% from $43.9M at year‑end 2024 to $32.0M
- Management plans to reduce quarterly dividend to $0.10 starting Q1 2026
Insights
Quarter shows declining revenue and profitability; restructuring aims to cut costs while liquidity falls but remains sizable.
Natural Health Trends reported
Management expects
Watch quarterly revenue trends, the realized run‑rate of the
– Orders decreased
– Restructuring initiatives expected to achieve
– Declared a quarterly cash dividend of
LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the quarter ended September 30, 2025.
Third Quarter 2025 Financial Highlights
- Revenue of
$9.5 million decreased11% compared to$10.7 million in the third quarter of 2024 in part due to the timing of a product promotion and the presale of our new skincare line at the end of September 2025 in Hong Kong. - Operating loss was
$495,000 compared to$275,000 in the third quarter of 2024 attributable partially to the timing of the product promotion and the new product presale mentioned above, as well as the writeoff of components inventory related to discontinued products during the third quarter of 2025. - Net loss was
$431,000 , or$0.04 per diluted share, compared to net income of$35,000 , or breakeven per diluted share, in the third quarter of 2024. Despite the loss before income taxes, tax expense of$142,000 was recognized in the third quarter. - The number of Active Members1 was 28,030 at September 30, 2025 compared to 30,870 at December 31, 2024 and 30,880 at September 30, 2024.
| 1 | Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period. |
Year-to-Date 2025 Financial Highlights
- Revenue of
$30.0 million decreased7% compared to$32.1 million in the first nine months of 2024. - Operating loss was
$1.2 million compared to$878,000 in the first nine months of 2024. - Net loss was
$294,000 , or$0.03 per diluted share, compared to net income of$396,000 , or$0.03 per diluted share, in the first nine months of 2024.
Management Commentary
“The economic outlook in our largest market remains challenging in the near term. We are undertaking a major restructuring, which we expect will result in
Mr. Sharng continued, “These actions will enable investments in new systems and technologies, including an AI-enabled marketing app and a member-interface business suite, as well as new marketing initiatives designed to drive member growth and engagement. By aligning costs with global sales performance, we are positioning the company for sustainable growth, profitability, and long-term value creation.”
Balance Sheet and Cash Flow
- Net cash used in operating activities was
$5.0 million in the first nine months of 2025 compared to$3.5 million in the first nine months of 2024. Before tax installment payments, the liability of which arose from the 2017 U.S. Tax Cuts and Jobs Act (the “Tax Act”), cash provided by operating activities was$16,000 in the first nine months of 2025 compared to$514,000 in the first nine months of 2024. The Tax Act liability is now fully paid. - Total cash, cash equivalents and marketable securities were
$32.0 million at September 30, 2025, down from$43.9 million at December 31, 2024. - On November 3, 2025, the Company’s Board of Directors declared a quarterly cash dividend of
$0.20 on each share of common stock outstanding. The dividend will be payable on November 28, 2025 to stockholders of record as of November 18, 2025.
Third Quarter 2025 Financial Results Conference Call
Management will host a conference call to discuss the third quarter 2025 financial results today, Wednesday, November 5, 2025 at 11:30 a.m. Eastern Time. The conference call details are as follows:
| Date: | Wednesday, November 5, 2025 |
| Time: | 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time |
| Dial-in: | 1-800-330-6730 |
| Participant ID: | 236986 |
For those unable to participate during the live broadcast, a replay of the call will be available on the Company's Investor Relations website at https://ir.naturalhealthtrendscorp.
About Natural Health Trends Corp.
Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.
Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Forward-looking statements in this press release include statements relating to the anticipated effect of restructuring activities, including expected operational efficiencies and cost savings resulting therefrom, statements regarding technology investments, future growth and profitability, and statements relating to future dividends, the declaration and payment of which will be at the sole discretion of the Company's Board of Directors. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on February 21, 2025 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED BALANCE SHEETS (In thousands, except share data) | |||||||
| September 30, 2025 | December 31, 2024 | ||||||
| (Unaudited) | |||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 14,336 | $ | 13,533 | |||
| Marketable securities | 17,672 | 30,407 | |||||
| Inventories | 2,154 | 3,272 | |||||
| Other current assets | 3,726 | 3,771 | |||||
| Total current assets | 37,888 | 50,983 | |||||
| Property and equipment, net | 170 | 190 | |||||
| Operating lease right-of-use assets | 2,031 | 2,498 | |||||
| Restricted cash | 35 | 34 | |||||
| Deferred tax asset | 246 | 382 | |||||
| Other assets | 1,881 | 1,272 | |||||
| Total assets | $ | 42,251 | $ | 55,359 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 1,011 | $ | 895 | |||
| Income taxes payable | 7 | 4,908 | |||||
| Accrued commissions | 1,751 | 2,021 | |||||
| Other accrued expenses | 1,484 | 1,425 | |||||
| Deferred revenue | 6,011 | 6,428 | |||||
| Amounts held in eWallets | 2,977 | 3,286 | |||||
| Operating lease liabilities | 991 | 1,127 | |||||
| Other current liabilities | 523 | 709 | |||||
| Total current liabilities | 14,755 | 20,799 | |||||
| Deferred tax liability | 173 | 174 | |||||
| Operating lease liabilities | 1,175 | 1,514 | |||||
| Total liabilities | 16,103 | 22,487 | |||||
| Stockholders’ equity: | |||||||
| Preferred stock | — | — | |||||
| Common stock | 13 | 13 | |||||
| Additional paid-in capital | 85,004 | 84,901 | |||||
| Accumulated deficit | (33,547 | ) | (26,344 | ) | |||
| Accumulated other comprehensive loss | (925 | ) | (1,301 | ) | |||
| Treasury stock, at cost | (24,397 | ) | (24,397 | ) | |||
| Total stockholders’ equity | 26,148 | 32,872 | |||||
| Total liabilities and stockholders’ equity | $ | 42,251 | $ | 55,359 | |||
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (In thousands, except per share data) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net sales | $ | 9,477 | $ | 10,691 | $ | 30,027 | $ | 32,117 | |||||||
| Cost of sales | 2,490 | 2,765 | 7,880 | 8,376 | |||||||||||
| Gross profit | 6,987 | 7,926 | 22,147 | 23,741 | |||||||||||
| Operating expenses: | |||||||||||||||
| Commissions expense | 3,876 | 4,333 | 12,376 | 13,022 | |||||||||||
| Selling, general and administrative expenses | 3,606 | 3,868 | 10,944 | 11,597 | |||||||||||
| Total operating expenses | 7,482 | 8,201 | 23,320 | 24,619 | |||||||||||
| Loss from operations | (495 | ) | (275 | ) | (1,173 | ) | (878 | ) | |||||||
| Other income, net | 206 | 441 | 1,019 | 1,523 | |||||||||||
| Income (loss) before income taxes | (289 | ) | 166 | (154 | ) | 645 | |||||||||
| Income tax provision | 142 | 131 | 140 | 249 | |||||||||||
| Net income (loss) | $ | (431 | ) | $ | 35 | $ | (294 | ) | $ | 396 | |||||
| Net income (loss) per common share: | |||||||||||||||
| Basic | $ | (0.04 | ) | $ | 0.00 | $ | (0.03 | ) | $ | 0.03 | |||||
| Diluted | $ | (0.04 | ) | $ | 0.00 | $ | (0.03 | ) | $ | 0.03 | |||||
| Weighted average common shares outstanding: | |||||||||||||||
| Basic | 11,500 | 11,471 | 11,493 | 11,464 | |||||||||||
| Diluted | 11,500 | 11,490 | 11,493 | 11,488 | |||||||||||
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (In thousands) | |||||||
| Nine Months Ended September 30, | |||||||
| 2025 | 2024 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net income (loss) | $ | (294 | ) | $ | 396 | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||||
| Depreciation and amortization | 87 | 100 | |||||
| Net accretion of marketable securities | (317 | ) | (350 | ) | |||
| Share-based compensation | 103 | 109 | |||||
| Noncash lease expense | 852 | 825 | |||||
| Deferred income taxes | 139 | 62 | |||||
| Changes in assets and liabilities: | |||||||
| Inventories | 1,161 | 619 | |||||
| Other current assets | 682 | (110 | ) | ||||
| Other assets | (601 | ) | (250 | ) | |||
| Accounts payable | 114 | (441 | ) | ||||
| Income taxes payable | (4,901 | ) | (3,738 | ) | |||
| Accrued commissions | (314 | ) | (34 | ) | |||
| Other accrued expenses | 44 | 179 | |||||
| Deferred revenue | (422 | ) | 641 | ||||
| Amounts held in eWallets | (307 | ) | (501 | ) | |||
| Operating lease liabilities | (858 | ) | (851 | ) | |||
| Other current liabilities | (206 | ) | (111 | ) | |||
| Net cash used in operating activities | (5,038 | ) | (3,455 | ) | |||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Purchases of property and equipment | (63 | ) | (37 | ) | |||
| Purchases of marketable securities | (39,011 | ) | (44,839 | ) | |||
| Proceeds from maturities of marketable securities | 51,619 | 21,786 | |||||
| Net cash provided by (used in) investing activities | 12,545 | (23,090 | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Dividends paid | (6,909 | ) | (6,909 | ) | |||
| Net cash used in financing activities | (6,909 | ) | (6,909 | ) | |||
| Effect of exchange rates on cash, cash equivalents and restricted cash | 206 | 174 | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | 804 | (33,280 | ) | ||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period | 13,567 | 56,217 | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period | $ | 14,371 | $ | 22,937 | |||
| SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: | |||||||
| Right-of-use assets obtained in exchange for operating lease liabilities | $ | (83 | ) | $ | 191 | ||
CONTACT:
Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (U.S.): 310-541-0888
investor.relations@nhtglobal.com